FI20001402A - Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi - Google Patents

Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi Download PDF

Info

Publication number
FI20001402A
FI20001402A FI20001402A FI20001402A FI20001402A FI 20001402 A FI20001402 A FI 20001402A FI 20001402 A FI20001402 A FI 20001402A FI 20001402 A FI20001402 A FI 20001402A FI 20001402 A FI20001402 A FI 20001402A
Authority
FI
Finland
Prior art keywords
packaging
preparation
lactic acid
acid bacterial
bacterial tablets
Prior art date
Application number
FI20001402A
Other languages
English (en)
Swedish (sv)
Other versions
FI20001402A0 (fi
Inventor
Yves Delatte
Original Assignee
Yves Delatte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yves Delatte filed Critical Yves Delatte
Priority to FI20001402A priority Critical patent/FI20001402A/fi
Publication of FI20001402A0 publication Critical patent/FI20001402A0/fi
Priority to AU69154/01A priority patent/AU6915401A/en
Priority to PCT/FI2001/000552 priority patent/WO2001095918A1/en
Publication of FI20001402A publication Critical patent/FI20001402A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI20001402A 2000-06-13 2000-06-13 Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi FI20001402A (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20001402A FI20001402A (fi) 2000-06-13 2000-06-13 Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi
AU69154/01A AU6915401A (en) 2000-06-13 2001-06-12 A process for producing and packaging lactic acid bacteria tablets
PCT/FI2001/000552 WO2001095918A1 (en) 2000-06-13 2001-06-12 A process for producing and packaging lactic acid bacteria tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20001402A FI20001402A (fi) 2000-06-13 2000-06-13 Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi

Publications (2)

Publication Number Publication Date
FI20001402A0 FI20001402A0 (fi) 2000-06-13
FI20001402A true FI20001402A (fi) 2001-12-14

Family

ID=8558547

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001402A FI20001402A (fi) 2000-06-13 2000-06-13 Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi

Country Status (3)

Country Link
AU (1) AU6915401A (fi)
FI (1) FI20001402A (fi)
WO (1) WO2001095918A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413334B (de) * 2002-12-23 2006-02-15 Belihart Josephine Feste darreichungsformen mit lebenden milchsäurebakterien
FR2869622B1 (fr) * 2004-04-28 2008-04-18 Rhodia Chimie Sa Comprimes de micro-organismes pour ensemencement direct
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
FR2938405B1 (fr) * 2008-11-20 2011-04-22 Florane Complement alimentaire et procede de distribution d'un tel complement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
SE513815C2 (sv) * 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet
WO1998030235A1 (fr) * 1997-01-09 1998-07-16 Morinaga Milk Industry Co., Ltd. Comprimes de lactoferrine
SE515310C2 (sv) * 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav

Also Published As

Publication number Publication date
AU6915401A (en) 2001-12-24
WO2001095918A1 (en) 2001-12-20
FI20001402A0 (fi) 2000-06-13

Similar Documents

Publication Publication Date Title
LTPA2014005I1 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
HUP0300731A3 (en) Valsartan salts, process for their preparation and pharmaceutical compositions thereof
EE05179B1 (et) Ravimitena kasutatavad antikolinergikumid ning meetod nende valmistamiseks
HUP0004123A2 (en) Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
HUP0001949A3 (en) Refastenable packing and process for manufacturing refastenable packing
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE05215B1 (et) Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks
HUP0201399A2 (en) Package for a pharmaceutical product and method of sterilising the package
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
EE04311B1 (et) Asoolid, nende valmistamismeetod, kasutamine ravimina ja farmatseutiline kompositsioon
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
FI20000755A (fi) Menetelmä tuoteanturin muodostamiseksi ja tuoteanturi
AU2001257309A1 (en) Lactic acid food products
EE200100615A (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
FI20001402A (fi) Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi
AU2002231297A1 (en) Medical article sterilization method
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
FI20012116A (fi) Kaoliinituote ja menetelmä sen valmistamiseksi
HUP0002554A3 (en) New metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
HUP0100749A3 (en) New 6-amino- or 6-hydrazino-sulphonyl-3-quinolinyl-phosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them
AU2001260607A1 (en) Nitrile compounds and process for their preparation
HUP0002147A3 (en) Hydroxybenzoic acid derivatives, process for producing them and pharmaceutical compositions having antiplasmid activity comprising the said compounds